ACME Laboratories’ profit grows slightly in Jul-Mar

The ACME Laboratories Limited, which is engaged in the manufacturing, marketing, and distribution of pharmaceutical formulation products, has posted a 6 per cent rise in its net profit in the first nine months (July–March) of the current fiscal year.

The publicly traded company posted Tk 169 crore in net profit in the July-March period of fiscal 2022–23, compared to Tk 160 crore in the same period last fiscal.

Meanwhile, the company’s net profit stood at Tk 53.62 crore in the third quarter (January-March) of FY23, which was Tk 50.36 crore in the same period of the previous year.

The company’s consolidated earnings per share (EPS) rose to Tk 2.53 for Q3 this fiscal from Tk 2.38 for the same quarter of the last fiscal.

The drug maker’s EPS was Tk 7.98 for the July-March of the current fiscal against Tk 7.55 for the first nine months of the last fiscal.

Its net operating cash flow per share (NOCFPS) stood at Tk 6.82 for the July-March of FY23 against Tk 5.35 for the July-March of FY22.

The company’s net asset value (NAV) per share was Tk 107.48 as on March 31, 2023, which was and Tk 102.50 till June 30, 2022.

The ACME Laboratories is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical formula-tion products, which include human drugs in dosage forms like a tablet, capsule, dry syrup, cream, ointment, powder, injec-tion, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products.

It also offers veterinary drugs comprising dosage forms like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosage forms like liquid, capsule, tablet, cream, and ointment.

The products of the company are sold both in the domestic and international markets,. Its factory is situated in Dhamrai, Dhaka.

The company paid a 30 per cent dividend to its shareholders in the year ended in June 2022. The drug maker’s profits rose 34 per cent year-on-year to Tk 211 crore in the last fiscal year, when its earnings per share hit Tk 9.98.

ACME shares closed at Tk 85 per share on the Dhaka Stock Exchange (DSE) on Thursday.